Multifaceted Effect of Rubus Occidentalis on Hyperglycemia and Hypercholesterolemia in Mice with Diet-Induced Metabolic Diseases
Open Access
Abstract
Metabolic syndrome is characterized by a combination of several metabolic disorders, including obesity, hyperglycemia, and hyperlipidemia. A simultaneous occurrence is one of the most crucial features of metabolic syndrome; therefore, we selected an animal model in which this would be reflected. We fed C57BL/6N mice a high-fat diet for 23 weeks to develop metabolic syndrome and examined the efficacy of Rubus occidentalis (RO) for hyperglycemia and hypercholesterolemia. Oral administration of RO for 16 weeks improved hyperglycemia as indicated by significantly decreased fasting glucose levels and a glucose tolerance test. Improvements were also observed in hypercholesterolemia, in which significant decreases in serum total cholesterol, non-high-density lipoprotein (non-HDL) cholesterol, apolipoprotein A-1, and apolipoprotein B levels were observed. The time comparison of major biomarkers, observed at the initiation and termination of the experimental period, consistently supported the beneficial effects of RO on each metabolic phenotype. In addition, RO treatment attenuated the excessive fat accumulation in hepatic and adipose tissue by decreasing the size and number of lipid droplets. These results suggested that RO simultaneously exerted antihyperglycemic and antihyperlipidemic effects in mice with diet-induced metabolic syndrome.Keywords
Funding Information
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (314044-3)
This publication has 23 references indexed in Scilit:
- Nonanthocyanin Secondary Metabolites of Black Raspberry (Rubus occidentalis L.) Fruits: Identification by HPLC-DAD, NMR, HPLC-ESI-MS, and ESI-MS/MS AnalysesJournal of Agricultural and Food Chemistry, 2013
- Prevalence of metabolic syndrome in children and adolescents — the recent trends in South KoreaJournal of Pediatric Endocrinology and Metabolism, 2013
- Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional StrategiesFrontiers in Endocrinology, 2013
- The use of animal models in diabetes researchBritish Journal of Pharmacology, 2012
- Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemiaJournal of Lipid Research, 2012
- Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDLBritish Journal of Pharmacology, 2011
- Effects of aRubus coreanusMiquel supplement on plasma antioxidant capacity in healthy Korean menNutrition Research and Practice, 2011
- Prevalence of the Metabolic Syndrome Among Overweight and Obese College Students in KoreaJournal of Cardiovascular Nursing, 2010
- Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best PracticesClinical Chemistry, 2009
- Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.Journal of Clinical Investigation, 1993